Successful treatment of ulcerative necrobiosis lipoidica with JAK inhibitor.
Clicks: 270
ID: 95642
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
270 views
31 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #13 of 18 articles by views in journal of the european academy of dermatology and venereology : jeadv
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Necrobiosis lipoidica (NL) is a rare granulomatous disease that predominantly affects middle aged women and is often associated with diabetes mellitus and other metabolic disorders . About 30 % of the patients develop ulcerations within NL lesions on the lower leg, which complicate the course of disease and are often recalcitrant to standard wound care procedures . Systemic therapies for NL are reported only for single cases or in small case series with varying outcome . Randomized controlled trials are missing due to the character of NL as an orphan disease.
| Reference Key |
erfurtberge2020successfuljournal
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Erfurt-Berge, C;Sticherling, M; |
| Journal | journal of the european academy of dermatology and venereology : jeadv |
| Year | 2020 |
| DOI |
10.1111/jdv.16297
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.